Jinjin Lu

510 total citations
29 papers, 390 citations indexed

About

Jinjin Lu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Jinjin Lu has authored 29 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Complementary and alternative medicine. Recurrent topics in Jinjin Lu's work include Traditional Chinese Medicine Analysis (5 papers), Berberine and alkaloids research (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Jinjin Lu is often cited by papers focused on Traditional Chinese Medicine Analysis (5 papers), Berberine and alkaloids research (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Jinjin Lu collaborates with scholars based in China, United States and Indonesia. Jinjin Lu's co-authors include Qian Lin, Chaocheng Zhao, Wei Yang, Fang Liu, Xin Chang, Xianhui Lu, Yan Li, Weihong Cong, Qiqi Xin and Dong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Ethnopharmacology.

In The Last Decade

Jinjin Lu

25 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinjin Lu China 11 122 57 52 51 50 29 390
Kumar Shiva Gubbiyappa India 12 185 1.5× 57 1.0× 56 1.1× 36 0.7× 48 1.0× 52 498
Vadavanath Prabhakaran Vineetha India 14 206 1.7× 43 0.8× 31 0.6× 51 1.0× 44 0.9× 31 546
Yanni Yang China 12 202 1.7× 56 1.0× 36 0.7× 70 1.4× 86 1.7× 29 836
Wenjuan Zhang China 13 141 1.2× 33 0.6× 28 0.5× 26 0.5× 20 0.4× 36 498
Fawziah A. Al‐Salmi Saudi Arabia 14 83 0.7× 41 0.7× 29 0.6× 38 0.7× 61 1.2× 39 471
Hanan A. Soliman Egypt 14 153 1.3× 65 1.1× 45 0.9× 68 1.3× 135 2.7× 30 571
Mohamed Ahmed Eladl United Arab Emirates 17 246 2.0× 36 0.6× 51 1.0× 35 0.7× 47 0.9× 63 904
Hongmei Gao China 16 168 1.4× 43 0.8× 21 0.4× 58 1.1× 34 0.7× 46 652
Sananda Dey India 7 157 1.3× 24 0.4× 28 0.5× 31 0.6× 57 1.1× 22 651

Countries citing papers authored by Jinjin Lu

Since Specialization
Citations

This map shows the geographic impact of Jinjin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjin Lu more than expected).

Fields of papers citing papers by Jinjin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjin Lu. The network helps show where Jinjin Lu may publish in the future.

Co-authorship network of co-authors of Jinjin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjin Lu. A scholar is included among the top collaborators of Jinjin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjin Lu. Jinjin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Min, Jinjin Lu, Jing Liang, et al.. (2025). Targeted Hybrid Theranostic Nanocarriers Enhance Thrombolytic Therapy via the Integration of Chemical and Physical Action. ACS Applied Materials & Interfaces. 17(49). 66378–66390.
2.
Jin, Jialin, Dong Li, Jinjin Lu, et al.. (2025). Qishentaohong granules alleviate heart failure by modulating mitochondrial fission and mitophagy balance. Journal of Ethnopharmacology. 352. 120190–120190.
3.
Zhang, Jiarong, Min Gao, Jinjin Lu, et al.. (2023). Chondroitin sulfate modified calcium phosphate nanoparticles for efficient transfection via caveolin-mediated endocytosis. International Journal of Biological Macromolecules. 253(Pt 4). 127046–127046. 4 indexed citations
4.
5.
Li, Yingfei, Huiqing Liu, Qian Lin, et al.. (2023). Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine. Chinese Journal of Integrative Medicine. 29(7). 655–664. 3 indexed citations
6.
Liu, Jing, et al.. (2023). Astragaloside IV for Heart Failure: Preclinical Evidence and Possible Mechanisms, A Systematic Review and Meta-Analysis. Chinese Journal of Integrative Medicine. 29(7). 626–633. 5 indexed citations
7.
Li, Xingxing, et al.. (2022). Trimethylamine N-Oxide in Heart Failure: A Meta-Analysis of Prognostic Value. Frontiers in Cardiovascular Medicine. 9. 817396–817396. 28 indexed citations
8.
Chen, Cong, Jianglin Xu, Yun Cai, et al.. (2022). Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?. Frontiers in Cardiovascular Medicine. 8. 792592–792592. 27 indexed citations
9.
Liu, Xuefei, Jinjin Lu, Ying Li, Xiuying Yang, & Jinwei Qiang. (2022). Oral magnesium sulphate administration in rats with minimal hepatic encephalopathy: NMR-based metabolic characterization of the brain. Magnesium Research. 35(2). 39–50.
10.
11.
Li, Xingxing, Dong Li, Jing Liu, et al.. (2021). A Single-Central, Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial Protocol: A Clinical Effect Evaluation Study on the TCM Comprehensive Intervention Program for Chronic Heart Failure. Evidence-based Complementary and Alternative Medicine. 2021. 1–7. 2 indexed citations
12.
Chen, Cong, Qian Lin, Xueying Zhu, et al.. (2021). Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 646306–646306. 8 indexed citations
13.
Jia, Wenhao, Yan Li, Jie Wan, et al.. (2020). Effects of Xuezhitong in Patients with Hypertriglyceridemia: a Multicentre, Randomized, Double-Blind, Double Simulation, Positive Drug and Placebo Parallel Control Study. Cardiovascular Drugs and Therapy. 34(4). 525–534. 15 indexed citations
14.
Liu, Hailang, Shaogang Wang, Wei Zhu, et al.. (2019). Comparative efficacy of 22 drug interventions as medical expulsive therapy for ureteral stones: a systematic review and network meta-analysis. Urolithiasis. 48(5). 447–457. 10 indexed citations
15.
Zhu, Wei, Hailang Liu, Xinguang Wang, Jinjin Lu, & Weimin Yang. (2019). Long noncoding RNAs in bladder cancer prognosis: A meta-analysis. Pathology - Research and Practice. 215(6). 152429–152429. 9 indexed citations
16.
Liu, Jing, et al.. (2018). Effectiveness and Safety of Compound Chinese Medicine plus Routine Western Medicine in In‐Stent Restenosis: A Meta‐Analysis and Systematic Review. Evidence-based Complementary and Alternative Medicine. 2018(1). 6207524–6207524. 3 indexed citations
17.
Nong, Yibing, Yan Li, Jie Wan, et al.. (2017). Astragalus Granule Prevents Ca2+ Current Remodeling in Heart Failure by the Downregulation of CaMKII. Evidence-based Complementary and Alternative Medicine. 2017(1). 7517358–7517358. 8 indexed citations
18.
19.
Liu, Jing, Yan Li, Jie Wan, et al.. (2017). Conventional Acupuncture for Cardiac Arrhythmia: A Systematic Review of Randomized Controlled Trials. Chinese Journal of Integrative Medicine. 24(3). 218–226. 17 indexed citations
20.
Zhang, Jing, Jinjin Lu, Qichun Zhang, et al.. (2013). Simultaneous Screening and Identifying Four Categories of Particular Flavonoids in the Leaves of Murraya exotica L. by HPLC-DAD-ESI-MS-MS. Journal of Chromatographic Science. 52(2). 103–114. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kumar Shiva Gubbiyappa Breakdown of academic impact, for papers by Vadavanath Prabhakaran Vineetha Breakdown of academic impact, for papers by Yanni Yang Breakdown of academic impact, for papers by Wenjuan Zhang Breakdown of academic impact, for papers by Fawziah A. Al‐Salmi Breakdown of academic impact, for papers by Hanan A. Soliman Breakdown of academic impact, for papers by Mohamed Ahmed Eladl Breakdown of academic impact, for papers by Hongmei Gao Breakdown of academic impact, for papers by Sananda Dey
Rankless by CCL
2026